Brain tumor clues in spinal fluid: mayo clinic launches major biomarker hunt

NCT ID NCT04692324

Recruiting now Knowledge-focused Sponsor: Mayo Clinic Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study collects cerebrospinal fluid (CSF) from 400 adults with brain or spinal cord tumors to identify biomarkers—measurable signs of disease. Researchers hope these samples will help develop new strategies to diagnose, monitor, and treat brain tumors more effectively. Participants undergo a lumbar puncture to provide CSF, and their medical records are reviewed. The goal is to build a resource for future research, not to test a new treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors develop new ways to diagnose, monitor, and treat brain tumors using spinal fluid samples.
What could go wrong: This is an early-stage sample collection study, not a treatment trial. It may not lead to any new tests or therapies, and results may take years.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CENTRAL NERVOUS SYSTEM NEOPLASM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

central nervous system cancer central nervous system neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CENTRAL NERVOUS SYSTEM NEOPLASM

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Mayo Clinic in Rochester
RECRUITING

Rochester, Minnesota, 55905, United States

Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.